| | | | | | | |
 | MODERNA, INC. | -6.05% | 13.86% | -32.33% | -64.52% | 1,189.42% | 71 566 |
| IQVIA HOLDINGS INC. | -0.16% | -2.30% | -17.32% | -5.81% | 49.54% | 43 579 |
| SEAGEN INC. | -1.17% | -2.32% | 14.00% | 10.85% | 129.25% | 32 890 |
| ALNYLAM PHARMACEUTICALS, INC. | -2.48% | 53.89% | 32.70% | 12.37% | 178.57% | 27 695 |
 | CELLTRION, INC. | 3.93% | 13.71% | 6.82% | -20.54% | 50.03% | 21 572 |
| ICON PUBLIC LIMITED COMPANY | -0.06% | -3.37% | -25.19% | -3.72% | 48.32% | 18 900 |
| BIO-TECHNE CORPORATION | -4.00% | -0.60% | -30.38% | -24.85% | 87.50% | 14 718 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -0.79% | 3.71% | -18.98% | -39.69% | 90.93% | 12 703 |
| PHARMARON BEIJING CO., LTD. | 0.24% | -2.05% | -20.01% | -48.33% | 225.07% | 12 585 |
| QIAGEN N.V. | -1.56% | -0.28% | -12.41% | -6.78% | 33.56% | 11 259 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -2.50% | -11.61% | -42.90% | -47.45% | 62.26% | 11 212 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.21% | 0.78% | 7.00% | 25.21% | 274.45% | 10 520 |
| UNITED THERAPEUTICS CORPORATION | -0.19% | -4.08% | 1.04% | 5.10% | 167.55% | 9 908 |
 | GENSCRIPT BIOTECH CORPORATION | 0.35% | 1.61% | -17.25% | -24.67% | 57.39% | 7 662 |
| SYNEOS HEALTH, INC. | -1.21% | -14.13% | -34.14% | -20.15% | 32.27% | 7 028 |
| | | | | | | |
| | Durchschnitt | -1.03% | 3.12% | -12.62% | -16.87% | 178.41% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -1.85% | 7.33% | -12.36% | -21.63% | 350.66% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
